(Q67947471)
Statements
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study (English)
Slayton RE
Blessing JA
Look K
scientific article published on 01 May 1991